Ozempic maker Novo Nordisk to spend $4.1 billion to boost production

Novo Nordisk on Monday said it will invest $4.1 billion in a new Clayton, N.C., manufacturing facility as it works to meet surging demand for its popular injectable drugs Wegovy and Ozempic.

Previous post Disney’s ‘Inside Out 2’ could be the first billion-dollar movie of 2024
Next post Pool Corp. slashes profit outlook, citing ‘persistently weak’ demand for new swimming pools